Page 2,980«..1020..2,9792,9802,9812,982..2,9903,000..»

Arthritis: Spotlight on Stem Cell Research – Introduction

Posted: August 3, 2011 at 3:10 pm

(Part 1 of 5) Robert Klein, JD and Philip Pizzo, MD, gave the welcoming remarks for the "Spotlight on Arthritis," an educational event presented at the CIRM Governing Board meeting on January 30, 2009.

Original post:
Arthritis: Spotlight on Stem Cell Research - Introduction

Posted in Stem Cell Research | Comments Off on Arthritis: Spotlight on Stem Cell Research – Introduction

Stem Cell Therapy for Cerebral Palsy – Holly Catalano

Posted: August 2, 2011 at 11:59 pm

Holly is now able to crawl and sit up on her own just 7 weeks after her second treatment for cerebral palsy at the Stem Cell Institute in Panama City, Panama.

See the original post:
Stem Cell Therapy for Cerebral Palsy - Holly Catalano

Posted in Cell Therapy | Comments Off on Stem Cell Therapy for Cerebral Palsy – Holly Catalano

Human Embryonic Stem Cell History!

Posted: August 2, 2011 at 6:56 am

Advanced Cell Technology and the Jules Stein Eye Institute at UCLA collaborate to perform the first ever injections of RPE cells derived from hESCs to treat two forms of blindness. Stargardt's Macular Dystrophy and Age-Related Dry Macular Degeneration.

More here:
Human Embryonic Stem Cell History!

Posted in Stem Cell Videos | Comments Off on Human Embryonic Stem Cell History!

Sickle Cell Anemia: Stem Cell Gene Therapy – A Patient’s Perspective

Posted: August 2, 2011 at 1:18 am

(Part 2 of 2) Nancy Rene, a patient advocate for the Sickle Cell Foundation of California, spoke to the CIRM Governing Board at the "Spotlight on Disease Team Awards: Stem Cell Therapy for Sickle Cell Anemia" seminar. Through photos and stories, Rene described the impact of sickle cell anemia on her grandson's life. She also spoke about the importance of support services for sickle cell patients and continued research for a cure.

Read this article:
Sickle Cell Anemia: Stem Cell Gene Therapy - A Patient's Perspective

Posted in Stem Cell Therapy | Comments Off on Sickle Cell Anemia: Stem Cell Gene Therapy – A Patient’s Perspective

Manish Singh of ImmunoCellular Therapeutics, talks about targeting cancer stem cells

Posted: August 1, 2011 at 11:01 pm

Manish Singh, President

Continued here:
Manish Singh of ImmunoCellular Therapeutics, talks about targeting cancer stem cells

Posted in Stem Cell Videos | Comments Off on Manish Singh of ImmunoCellular Therapeutics, talks about targeting cancer stem cells

A New Era in Regenerative Medicine

Posted: August 1, 2011 at 9:47 pm

"Our discovery of the 'pure' human blood stem cell could open up a new era in regenerative medicine," says principal investigator John Dick, who holds a Canada Research Chair in Stem Cell Biology and is a Senior Scientist at the McEwen Centre for Regenerative Medicine and the Ontario Cancer Institute, University Health Network. Release available here: http://www.uhn.ca

The rest is here:
A New Era in Regenerative Medicine

Posted in Regenerative Medicine | Comments Off on A New Era in Regenerative Medicine

Poor Diet May Make COPD Worse, Study Finds

Posted: July 31, 2011 at 4:05 pm

(HealthDay News) -- Certain vitamin deficiencies may lead to decreased lung function in people with chronic obstructive pulmonary disorder (COPD), which includes emphysema and chronic bronchitis, says a new study.

For the study, 20 COPD patients (13 women, seven men) completed a questionnaire to assess their dietary intake of vitamins A, C, D, E and selenium, all of which contain cell-protecting antioxidants. A diet low in antioxidants -- as compared to national dietary intake requirements -- was common among the patients.

The percentages of deficiencies were: 25 percent (selenium), 45 percent (vitamin C), 90 percent (vitamin E), 55 percent (vitamin A), and 70 percent (vitamin D).

The researchers then measured the maximum amount of air the patients could exhale with force. All the patients with a selenium-deficient diet had decreased lung function. Among patients deficient in vitamins C, A, and D, only men had decreased lung function. Read more...

Ayurtox for Body Detoxification

Posted in Integrative Medicine | Comments Off on Poor Diet May Make COPD Worse, Study Finds

Clinical trial costs

Posted: July 31, 2011 at 4:05 pm

Based on a survey* of 21 drug makers, 12 biotechs, nine device makers and 23 contract research organizations, PharmaLot has recently published the following metrics for current clinical trial costs (see full article here)
Average per-patient trial costs across all therapeutic areas:
Phase I: $21,883
Phase II: $36,070
Phase IIIa: $47,523
Phase IIIb: $47,095
Phase IV: $17,042
Average cost per patient for a cardiovascular trial:
Phase II: $33,700
Phase IIIa: $21,750
Phase IIIb: $6,830
In oncology, the average per patient trial cost:
Phase II: $73,303
Phase IIIa: $57,207
Phase IIIb: $65,900
For central nervous system disorders:
Phase II: $28,197
Phase IIIa: $33,768
Phase IIIb: $41,824
For diabetes:
Phase II: $ 8,854
Phase IIIa: $12,667
Phase IIIb: $10,700
Anyone have any thoughts or data as to how this compares to cell therapy trials?
--Lee
*survey conducted by Cutting Edge Information.
Posted in Regenerative Medicine | Comments Off on Clinical trial costs

International Stem Cell Corporation to Hold Business Update Conference Call on August 10

Posted: July 31, 2011 at 4:05 pm

International Stem Cell Corporation (OTCBB: ISCO) today announced that it will hold a conference call and webcast on Wednesday, August 10, 2011 at 11:00 a.m. Eastern (8:00 a.m. Pacific). Chairman Ken Aldrich will provide an update on the business, including plans for the future development of the skin care line; animal and potential clinical trials for Parkinson's and liver diseases; and the Company's business strategy for 2011 and longer term.
Individuals interested in listening to the conference call may do so by dialing 877-407-8033 for domestic callers, or 201-689-8033 for international callers, or from the webcast on the investor relations section of the Company's Web site athttp://www.intlstemcell.com.
A telephone replay will be available approximately one hour after the conclusion of the call by dialing 877-660-6853 for domestic callers, or 201-612-7415 for international callers, and entering the account code: 286 and the Conference ID: 376367. The webcast will be available on the Company's Web site for 60 days following the completion of the call.
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.

To subscribe to receive ongoing corporate communications, please click on the following link: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
International Stem Cell Corporation
Kenneth C. Aldrich, Chairman
760-940-6383
kaldrich@intlstemcell.com

or
Lippert/Heilshorn & Associates
Don Markley, 310-691-7100
dmarkley@lhai.com
Posted in Stem Cells, Stem Cell Therapy | Comments Off on International Stem Cell Corporation to Hold Business Update Conference Call on August 10

Poor Diet May Make COPD Worse, Study Finds

Posted: July 31, 2011 at 4:04 pm

(HealthDay News) -- Certain vitamin deficiencies may lead to decreased lung function in people with chronic obstructive pulmonary disorder (COPD), which includes emphysema and chronic bronchitis, says a new study.

For the study, 20 COPD patients (13 women, seven men) completed a questionnaire to assess their dietary intake of vitamins A, C, D, E and selenium, all of which contain cell-protecting antioxidants. A diet low in antioxidants -- as compared to national dietary intake requirements -- was common among the patients.

The percentages of deficiencies were: 25 percent (selenium), 45 percent (vitamin C), 90 percent (vitamin E), 55 percent (vitamin A), and 70 percent (vitamin D).

The researchers then measured the maximum amount of air the patients could exhale with force. All the patients with a selenium-deficient diet had decreased lung function. Among patients deficient in vitamins C, A, and D, only men had decreased lung function. Read more...

Ayurtox for Body Detoxification

Posted in Integrative Medicine | Comments Off on Poor Diet May Make COPD Worse, Study Finds

Page 2,980«..1020..2,9792,9802,9812,982..2,9903,000..»